rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
One hundred and five patients with major depression and 74 unrelated matched controls were analyzed for a silent 1287G/A polymorphism (NET-8) in exon 9 of the NET gene.
|
10512149 |
1999 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Our results suggest that CYP2D6 ultra-rapid metabolizer status contributes to venlafaxine-XR treatment remission in MDD patients; in particular, there is a PK-PD interaction with treatment remission associated with CYP2D6 URM phenotype and SLC6A4 5-HTTLPR L/L or SLC6A2 G1287A G/A genotype, respectively.
|
30578947 |
2019 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Association between T-182C, G1287A polymorphism in NET gene and suicidality in major depressive disorder in Chinese patients.
|
29703117 |
2018 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In the haplotype analysis, TAA (rs2242446-rs28386840-rs5569, from left to right) was associated with suicide attempts in MDD, although the significance (p=0.043) disappeared after Bonferroni correction.
|
24655776 |
2014 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Our findings suggest that the NET T-182C and G1287A polymorphisms are not susceptibility factors for MDD.
|
23648227 |
2013 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Relationship between G1287A of the NET Gene Polymorphisms and Brain Volume in Major Depressive Disorder: A Voxel-Based MRI Study.
|
26960194 |
2016 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In a case control association study we investigated the newly identified T-182C polymorphism and an already known G1287A polymorphism in exon 9 of the NET gene in a sample of 193 patients with major depression and 136 healthy, non-related controls.
|
11927173 |
2002 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We analyzed the NET promoter T-182C polymorphism and another silent polymorphism G1287A in exon 9 of the NET gene with a polymerase chain reaction (PCR)-based method in 216 patients with major depression and 210 unrelated, age-and sex-matched healthy control subjects.
|
17353941 |
2007 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In self-identified white patients with major depressive disorder (N=126) treated with open-label duloxetine (60-120 mg/d), a significant association of (P=0.020) of a composite risk score (based on SLC6A2 rs5569 [G1287A] AA, HTR1A rs6295 [C(-1019)G] GG, and COMT rs174697 AA/AG) with 17-item Hamilton Depression Rating Scale total score change from baseline to 12 weeks was observed.
|
22727709 |
2012 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Different combinations of T-182C and the G1287A polymorphisms of NET gene might increase morbidity risk of M</span>D subpopulations.
|
26061302 |
2015 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
To our knowledge, this is the first report showing that the G1287A polymorphism modifies rural residency as a risk factor for MDD.
|
19564048 |
2009 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The present study suggests that the combined effect of rs2242446 and rs5569 in the NET gene could modify the response to the negative life events in triggering MD.
|
18779921 |
2008 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In conclusion, NET gene rs5569 polymorphism could increase the risk of MDD, especially among Asians.
|
30292339 |
2018 |
rs5569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
NET G1287A polymorphism appears not to be an important factor in susceptibility to MDD in a Japanese population.
|
17917281 |
2007 |